Literature DB >> 12612216

Intraamniotic endotoxin increases lung antioxidant enzyme activity in preterm lambs.

Ilene R S Sosenko1, Alan H Jobe.   

Abstract

Proinflammatory stimulation resulting from intraamniotic endotoxin improves lung function, increases surfactant protein mRNA expression and protein content, increases alveolar and lung saturated phosphatidylcholine pools, and accelerates lung morphometric maturation in fetal sheep. The mechanism for induction of lung maturation does not involve an increase in fetal cortisol. The effect of endotoxin on the maturation of a different lung system, the antioxidant enzyme (AOE) system, has not been examined. Therefore, we hypothesized that intraamniotic endotoxin would produce acceleration of AOE activity in fetal sheep at similar doses and schedule of administration to those producing lung functional and surfactant maturation. In a dose-response study, intraamniotic injections of 1, 4, 20, or 100 mg of Escherichia coli 055:beta5 endotoxin were administered 7 d before preterm delivery of sheep at 125 d gestation. In a study examining time interval of administration before delivery, 20 mg of endotoxin was injected at either 1-, 2-, 4-, 7-, or 15-d intervals before preterm delivery at 125 d. Doses of 1-100 mg of endotoxin produced significant increases in glutathione peroxidase activity; doses of 4-100 mg significantly increased catalase activity, whereas doses of 20-100 mg resulted in significant increases in total superoxide dismutase activity. Glutathione peroxidase activity was elevated within 2 d, whereas superoxide dismutase was increased by 4 d and catalase activity increased by 7 d after endotoxin. No AOE increases were sustained for 15 d. Endotoxin increased fetal lung AOE activity at similar dosing amounts and intervals to those producing maturation of lung function and surfactant. Thus, mechanisms involving proinflammatory stimulation, unrelated to glucocorticoid hormones, can induce maturation of the AOE system of the fetal lung.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612216     DOI: 10.1203/01.PDR.0000055769.19891.C4

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Long term consequences of oxygen therapy in the neonatal period.

Authors:  Alan H Jobe; Suhas G Kallapur
Journal:  Semin Fetal Neonatal Med       Date:  2010-05-10       Impact factor: 3.926

2.  Moderate postnatal hyperoxia accelerates lung growth and attenuates pulmonary hypertension in infant rats after exposure to intra-amniotic endotoxin.

Authors:  Jen-Ruey Tang; Gregory J Seedorf; Vincent Muehlethaler; Deandra L Walker; Neil E Markham; Vivek Balasubramaniam; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-13       Impact factor: 5.464

3.  Airway inflammatory cell responses to intra-amniotic lipopolysaccharide in a sheep model of chorioamnionitis.

Authors:  Fook-Choe Cheah; J Jane Pillow; Boris W Kramer; Graeme R Polglase; Ilias Nitsos; John P Newnham; Alan H Jobe; Suhas G Kallapur
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-31       Impact factor: 5.464

4.  Intratracheal administration of endotoxin attenuates hyperoxia-induced lung injury in neonatal rats.

Authors:  Jae Won Shim; Yun Sil Chang; Won Soon Park
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

Review 5.  Animal Models, Learning Lessons to Prevent and Treat Neonatal Chronic Lung Disease.

Authors:  Alan H Jobe
Journal:  Front Med (Lausanne)       Date:  2015-08-07

Review 6.  Can the preterm lung recover from perinatal stress?

Authors:  Matthias C Hütten; Tim G A M Wolfs; Boris W Kramer
Journal:  Mol Cell Pediatr       Date:  2016-04-13

7.  Prenatal Maternal Lipopolysaccharide and Mild Newborn Hyperoxia Increase Intrapulmonary Airway but Not Vessel Reactivity in a Mouse Model.

Authors:  Margaret E Kuper-Sassé; Peter M MacFarlane; Catherine A Mayer; Richard J Martin; Y S Prakash; Christina M Pabelick; Thomas M Raffay
Journal:  Children (Basel)       Date:  2021-03-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.